Subject(s)
Influenza Vaccines , Influenza, Human , Pregnancy Complications, Infectious , Whooping Cough , Pregnancy , Female , Humans , Influenza, Human/prevention & control , Cross-Sectional Studies , Whooping Cough/prevention & control , Vaccination , Influenza Vaccines/therapeutic use , Health Knowledge, Attitudes, Practice , Surveys and Questionnaires , Pregnancy Complications, Infectious/prevention & control , Patient Acceptance of Health CareABSTRACT
OBJECTIVES: The objective of the study was to evaluate the incidence of venous thromboembolism (VTE) in patients who have been admitted for adenomyosis at our institute and describe their clinical characteristics and management. MATERIALS AND METHODS: A retrospective review of the medical records of all patients who were admitted to the gynecology ward between January 2015 and August 2016 was conducted, and all patients who had adenomyosis were included in this study. Clinical details that were evaluated included age, parity, body mass index, significant comorbidities, size of the uterus on physical examination, the size of the adenomyoma (if present) on pelvic ultrasonography, initial hemoglobin, and hematocrit on admission, whether blood transfusion was required, acute and long-term treatment and whether or not there were any associated VTE and treatment given. RESULTS: Forty-one patients were included in this study. Five (12.2%) out of the 41 patients had associated VTE; all five had pulmonary embolism (PE), while two also had a concurrent left lower limb deep-vein thrombosis. Three out of the five patients had worsening menorrhagia following anticoagulation, which gonadotropin-releasing hormone analogs were effective in controlling. Four of the five patients eventually underwent a hysterectomy for long-term management of adenomyosis. CONCLUSION: This case series describes a few clinical cases where VTE (particularly PE) has been observed with adenomyosis, the challenges in managing these patients, and effective treatment approaches.
